GLP-1 AGONISTS: EFFECT IN MANAGEMENT OF DIABETES AND WEIGHT LOSS IN OLDER ADULTS WITH OVERWEIGHT AND OBESITY

被引：0
|
作者：
Pendrey, Anna [1 ]
机构：
[1] Indiana Univ, Indianapolis, IN USA
来源：
INNOVATION IN AGING | 2023年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
igad104.22
引用
收藏
页码：695 / 695
页数：1
相关论文
共 50 条
  • [21] GLP-1 agonists in type 1 diabetes
    Pettus, Jeremy
    Hirsch, Irl
    Edelman, Steven
    CLINICAL IMMUNOLOGY, 2013, 149 (03) : 317 - 323
  • [22] GLP-1 receptor agonists in the treatment of obesity
    Disse, E.
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2024, 28 (01): : 18 - 21
  • [23] Comment on "Obesity/Type 2 Diabetes: GLP-1 Agonist Tirzepatide Promotes Weight Loss"
    Blueher, Matthias
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (08) : 415 - 416
  • [24] Glp-1 Receptor Agonists Among LVAD Patients with Diabetes and Obesity; Effect on Comorbid Conditions
    Mekhaimar, M.
    Correa, A.
    Hamo, C.
    Doshi, A.
    Young, A.
    Roldan, J.
    Lala, A.
    Mitter, S.
    Parikh, A.
    Mancini, D.
    Moss, N.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S449 - S449
  • [25] The role of GLP-1 receptor agonists as weight loss agents in patients with and without type 2 diabetes
    Dar, Shujah
    Tahrani, Abd A.
    Piya, Milan K.
    PRACTICAL DIABETES, 2015, 32 (08) : 295 - 300
  • [26] Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high-dose GLP-1 receptor agonists and GLP-1 receptor-based co-agonists
    Goldenberg, Ronald M.
    Gilbert, Jeremy D.
    Manjoo, Priya
    Pedersen, Sue D.
    Woo, Vincent C.
    Lovshin, Julie A.
    OBESITY REVIEWS, 2024, 25 (03)
  • [27] Beyond Weight Loss: Evaluating Cardiovascular Advantages of GLP-1 Receptor Agonists
    Vezza, Teresa
    Victor, Victor M.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2024, : 505 - 507
  • [28] GLP-1 receptor agonists: Nonglycemic clinical effects in weight loss and beyond
    Ryan, Donna
    Acosta, Andres
    OBESITY, 2015, 23 (06) : 1119 - 1129
  • [29] Use of GLP-1 agonists for weight loss increases risk of GI AEs
    Reactions Weekly, 2023, 1978 (1) : 12 - 12
  • [30] GLP-1 agonists linked to adverse gastrointestinal events in weight loss patients
    Mahase, Elisabeth
    BMJ-BRITISH MEDICAL JOURNAL, 2023, 383 : 2330
12345